NCT00318643 2021-10-29
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer
Halozyme Therapeutics
Phase 1/2 Completed
Halozyme Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University Hospital Tuebingen